2022. Patient-Derived Organoids as a Predictive Assay: Concordance With Clinical Response in Colorectal Cancer. Translational Medicine & Therapeutics Journal. 1, 1 (Mar. 2022), 19–27. DOI:https://doi.org/10.5281/zenodo.22648824.